(Reuters) – Britain’s drug regulator on Thursday approved GSK and Vir Biotechnology’s antibody based COVID-19 treatment, Xevudy, for people with mild-to-moderate COVID-19 who are at high risk of developing severe…
Trending News
January 4, 2025
December 27, 2024
December 20, 2024
November 19, 2024
July 10, 2024